AAPP Scientific Poster Session Abstracts

Browse abstracts for all scientific posters that have been presented at the AAPP Annual Meeting.

Use the search box to quickly locate an abstract by any data in the column, including "PGY2"! The site search provides full-text search of all abstracts that have been presented at the AAPP Annual Meeting over the years.

Browse: 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024

Currently Viewing Abstracts from 2008

Title
A Double-Blind Placebo-Controlled Trial Comparing Paliperidone ER and Quetiapine in Patients With a Recent Acute Exacerbation of Schizophrenia
A Multi-Attribute Decision Making Model for Mood Stabilizer Selection Based on a Survey of Psychiatric Pharmacists.
A Noninferiority Comparison of Duloxetine and Venlafaxine XR for the Treatment of Adult Patients with Generalized Anxiety Disorder
A PERFORMANCE IMPROVEMENT PROGRAM TO EVALUATE THE SAFETY AND EFFICACY OF CHANTIX (VARENICLINE)
A PRELIMINARY ANALYSIS OF A PHARMACY OUTLIER MANAGEMENT PROGRAM IN A MEDICARE POPULATION
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF GUANFACINE EXTENDED RELEASE IN CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
A Retrospective Evaluation of Adherence with Recommended Monitoring Parameters During Treatment With Valproate and the Impact of Pharmacy Clinical Services
A RETROSPECTIVE REVIEW OF THE EFFECTS OF DEPRESSION ON WEIGHT LOSS POST-BARIATRIC SURGERY
A STUDY METHODOLOGY TO OPTIMALLY EVALUATE THE INTRA-PATIENT PHARMACODYNAMIC EFFECT OF SMALL CHANGES IN PLASMA VALPROIC ACID (VPA) CONCENTRATION VIA INTRAVENOUS SODIUM VALPROATE IN EPILEPSY PATIENTS EXHIBITING A PHOTOPAROXYSMAL RESPONSE.
Acute dystonic reaction with ziprasidone in a 13 year old due to a medication dosing error
ADOLESCENT ADHD: ATOMOXETINE MAINTENANCE EFFECTS ON AGE-APPROPRIATE DEVELOPMENTAL/ADAPTIVE FUNCTIONING
An Evaluation of the Efficacy and Safety of Duloxetine among Hispanic Americans with Major Depressive Disorder and Pain
Antidepressant Use in Bipolar Disorder: A Retrospective Study in a State Inpatient Psychiatric Hospital
Antipsychotic Induced Transaminase Elevation: A Case Series
Assessment of Depression After an Acute Myocardial Infarction
Assessment of Ethnicity on a Butyrylcholinesterase Variant in Alzheimer’s Patients and Normal Volunteers
Attitudes and Beliefs of Pharmacy Students toward the Mentally Ill
ATTITUDES OF PHARMACY STUDENTS TOWARD MENTAL ILLNESS ACROSS THE PROFESSIONAL CURRICULUM
AUTOMATIC THERAPEUTIC SUBSTITUTION (ATS) OF RISPERIDONE AND PALIPERIDONE IN BOTH ADULT AND PEDIATRIC PATIENTS
Cardiac-Related Abnormalities on Autopsy in People with Severe Mental Illness Treated with Clozapine
CHRONIC LEUKOCYTOSIS ASSOCIATED WITH CLOZAPINE TREATMENT
CIPROFLOXACIN-INDUCED PSYCHOSIS: A CASE REPORT
Clinical Interventions in a large urban psychiatric hospital
Clinical Pharmacist Involvement in Assertive Community Treatment (ACT) for the Chronically Mentally Ill
Clinician Adherence to Published Metabolic Monitoring Parameters for Use with Second-Generation Antipsychotics in a Private Inpatient Psychiatric Facility
Clozapine-Treated Psychiatric Inpatients Post-Smoking Cessation: Effect on Psychiatric Symptomatology
Color blindness associated with olanzapine
Comparative Safety and Tolerability of Alzheimer's Disease Treatment
Comparison of antipsychotic injections utilized within twenty-four hours of mechanical restraints
Cross-sectional evaluation of single versus combination antipsychotic treatment and clinical outcomes in an inpatient psychiatric facility
Determining the Correlation Between Cardiovascular Disease and Depression on an Inpatient Family Medicine Service
DEVELOPMENT OF AN EVIDENCE BASED HANDBOOK FOR HEALTHCARE PROVIDERS ON EXPOSURE TO PSYCHOTROPIC MEDICATIONS AND OTHER SUBSTANCES DURING PREGNANCY AND LACTATION
DEVELOPMENT OF INTERVENTION S STRATEGIES IN THE USE OF MULTIPLE ANTIPSYCHOTICS TO IMPROVE CLIENT HEALTH OUTCOMES
Discharge follow-up with a pharmacist study: incorporating pharmacist-provided discharge education and medication reconciliation with an outpatient follow-up service for patients with psychiatric illness discharged to an outpatient day treatment program
DISPOSITION OF D-SERINE IN HEALTHY ADULTS
Duloxetine 60 to 120 mg Once Daily for the Prevention of Relapse in Adults with Generalized Anxiety Disorder: A Double-blind Placebo-controlled Trial
Duloxetine Hepatic Effects: 2006 Review
DULOXETINE-INDUCED TAKOTSUBO CARDIOMYOPATHY: A CASE REPORT
Early Onset of Antipsychotic Action in Schizophrenia: A Clinical Marker Discriminating Active Drug from Placebo
Early Symptom Change Prediction of Remission in Depression Treatment
Edema and Arthralgia Associated With Olanzapine: A Case Report
Effects of adding loxapine to an atypical antipsychotic in patients with schizophrenia or schizoaffective disorder
Effects of optimal medication therapy management of depression in human immunodeficiency virus (HIV) infected patients on associated virologic and immunologic outcomes.
Efficacy and Safety of Fixed-Dose Desvenlafaxine Succinate at 50 mg/d and 100 mg/d in Outpatients With Major Depressive Disorder in 2 Placebo-Controlled Trials
EFFICACY AND SAFETY OF LISDEXAMFETAMINE DIMESYLATE IN ADULTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
Epinephrine Abuse: A Case Report
Ethylglucuronide (EtG) assessed by two methods following fragrance and hand sanitizer exposure in men and women
Evalatuion of Monitoring of Atypical Antipsychotic-Related Metabolic Adverse Effects at an Academic VA
Evaluating Patients Who are Incompetent to Proceed in a Mental Health Facility
Evaluation of combination antipsychotic treatment in an acute adult psychiatric inpatient unit of a large urban hospital
Evaluation of Lacosamide in Diabetic Neuropathic Pain Trials
Evaluation of medication adherence among patients discharged from a Veteran’s Affairs residential post traumatic stress disorder treatment program
Exacerbation of Psychosis: A Case of Possible Varenicline-Mediated Effects in an Intellectually Disabled Adult
False-positive phencyclidine immunoassay caused by venlafaxine
First exposures in prescription opioid abusers
Gabapentin for Severe Behavioral Disturbance Associated with Huntington’s Disease: A Case Report
Genetic Association Study of Serum Prolactin Increase in Olanzapine/fluoxetine Combination-treated Patients with Bipolar I Depression
Hospitalization and Medication Compliance Associated with the Use of Long-Acting Risperidone Injection for the Treatment of Schizophrenia and Schizoaffective Disorder in a Veteran Population
Hyperprolactinemia associated with oral ziprasidone
Impact of CBC Sampling Time Change on WBC and ANC Values in Clozapine Patients
Implementation of metabolic monitoring guidelines in an outpatient psychiatry clinic on patients receiving antipsychotic medications
IMPROVING MEDICATION MANAGEMENT SUPPORT FOR OLDER ADULTS
Increasing adverse drug reaction reporting in a 100 bed acute care behavioral health center
Innovative Practice: The Pharmacist as an Expert Witness: Psychotropic Medication Use and Breastfeeding
Interaction Between Apolipoprotein E Genotype and Serum Interleukin-6 Levels in Predicting Cognitive Decline Among Rural Elders
Intramuscular ziprasidone usage by emergency medical services
Lacosamide: Efficacy and Safety as Oral Adjunctive Treatment for Partial-Onset Seizures
LISDEXAMFETAMINE DIMESYLATE EFFECT SIZE IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
LITHIUM – INDUCED DIABETES INSIPIDUS?
Management of trauma-related nightmares in an eating disorder patient
Medication Reconciliation at a Psychiatric Hospital
Memantine Discontinuation in Nursing Home Residents with Alzheimer’s Disease is Associated with Increased Psychotropic Drug Use and Decreased Weight
METABOLIC CONSEQUENCES OF USING LOW-DOSE QUETIAPINE FOR INSOMNIA IN PSYCHIATRIC PATIENTS
MILNACIPRAN FOR THE TREATMENT OF FIBROMYALGIA SYNDROME: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
MILNACIPRAN TREATMENT FOR FIBROMYALGIA SYNDROME: ONE-YEAR DURABILITY OF RESPONSE
Minimal lot-to-lot variability in mg tablet content for enteric-coated, delayed-release divalproex sodium and in divalproex sodium extended-release tablets.
Minimal variability for in-vitro dissolution profiles for numerous batches of extended-release divalproex sodium tablets, implicating predictability in in-vivo bioavailability.
Neuroleptic malignant syndrome after discontinuation of olanzapine: A case report
Olanzapine Maintenance Treatment for Bipolar I Disorder: Numbers Needed to Treat or Harm
ONCE-DAILY ATOMOXETINE FOR ADULT ADHD: A 6-MONTH, DOUBLE-BLIND TRIAL
Perceptions of Mood Stabilizing Medications for the Treamtent of Bipolar Disorder: A Survey of Psychiatric Pharmacists
Pharmacist Interventions to Decrease Use and Increase Documentation of Multiple Antipsychotic Agents at Discharge
Phosphodiesterase 11A (PDE11A) Gene is Associated with Lithium Response in Bipolar Disorder
Physiological Response to a Speech Stressor Presented in a Virtual Reality Environment
PRESMA study: Pilot study assessing the impact of systematic monitoring by a pharmacist on the management of metabolic side effects among patients taking an atypical antipsychotic
Promotion of Health and Wellness in Coal Miners Through a Pharmacist-Managed Tobacco Cessation Program
Psychiatric Antecedents and Subsyndromal Anxiety in Patients with Alcohol Dependence: Effects of Acamprosate
Psychiatric Pharmacy in a University Student Health System
Psychotropic Medication Adherence: Implications for Post-Release Success
RANDOMIZED, DOUBLE-BLIND STUDY OF GUANFACINE EXTENDED RELEASE IN CHILDREN AGED 6 TO 17 YEARS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
RATES OF ADHERENCE TO ANTIPSYCHOTIC MEDICATIONS IN A POPULATION OF PATIENTS WITH BIPOLAR DISORDER OR SCHIZOPHRENIA IN A COMMUNITY MENTAL HEALTH SETTING – EVALUATION OF 60-DAY REFILL DATA
Recent Findings of Two National Alliance on Mental Illness (NAMI ) Surveys:
Rehospitalization after Discontinuation of Paliperidone ER in Patients with Schizophrenia
Rehospitalization Rates Among Patients with Schizophrenia
Relationship Between Function and Employment Status in Patients With Schizophrenia
Relationship between the catechol-o-methyltransferase (COMT) Val158Met polymorphism and antipsychotic response in first episode psychosis
Resource Use Patterns Over 24 Months for Patients With Schizophrenia Who Initiated Therapy With Risperidone Long-Acting Injectable
Results of initial metabolic clinic screening of 93 patients treated with antipsychotics
Retrospective evaluation of a potential interaction between warfarin and trazodone in patients stabilized on warfarin.
Retrospective Evaluation of Ropinirole Associated Psychotic Symptoms in an Outpatient Population Treated for Restless Leg Syndrome and Parkinson’s Disease
SCREENING AND MONITORING FOR EXACERBATIONS OF PSYCHIATRIC ILLNESS AND NEW ONSET PSYCHIATRIC SYMPTOMS IN PATIENTS ENROLLED IN A TOBACCO CESSATION PROGRAM
Seizure Prophylaxis in a Patient with Toxic Clozapine Levels
STUDY OF CONCURRENT USE OF ANTIPSYCHOTICS IN THE CALIFORNIA MEDICAID PROGRAM
Temporary Inpatient Smoking Cessation: Clinical Implications for Outpatient Antipsychotic Therapy
The Co-administration of Clozapine and Fluvoxamine: An Evaluation of Effectiveness and Safety
The Effect of Tai chi in Reducing Anxiety in an Ambulatory Population
THE EFFICACY AND SAFETY OF MILNACIPRAN IN THE TREATMENT OF FIBROMYALGIA SYNDROME
The Investigator’s Assesment Questionnaire (IAQ) in Clinical Practice Compared With the Simpson Angus Scale, Abnormal Involuntary Movement Scale and Barnes Akathisia Scale
The metabolic impact of mood stabilizers, antidepressants and antipsychotics on bipolar and depressed adolescent males.
The Role of the Pharmacist in the Recovery Model for Treating Mental Illness
The Use of Memantine in the VA Population
The Value of specialty care in the Treatment of Major Depression: A Kentucky Medicaid Evaluation
Tobacco Smoking Behaviors in Bipolar Disorder and Normal as well as Psychiatric Controls
Topiramate for Treatment of Postherpetic Neuralgia
Topiramate reduces overall symptom burden and nightmares associated with combat-related post-traumatic stress disorder
Total valproic acid concentrations from oral enteric-coated divalproex sodium are predictable within epilepsy patients from day-to-day at the same time of day.
Treatment of a clozapine-induced seizure with lamotrigine
Treatment of the Alcohol Withdrawal Syndrome with Benzodiazepines in an Inpatient VA Setting
Use of an online community website to enhance communication on clinical pharmacy rotations
Weight Gain and the Investigator’s Assessment Questionnaire (IAQ): Clinician Rated Scoring vs. Actual Changes in Patient Weight
XR vs XL vs CR vs ER vs SA vs Chrono: What do these suffixes really mean as it pertains to modified-release AEDs?